Related Articles |
Cancer Cell. 2020 Jan 13;37(1):5-7
Authors: Gay CM, Parseghian CM, Byers LA
Abstract
In a recent issue of Science, Russo et al. observe that colorectal cancer cells, when exposed to the pressure of EGFR- and BRAF-targeted therapies, transiently alter their transcriptional profiles to foster mutagenesis, thereby enhancing the stochastic development of acquired resistance mutations.
PMID: 31951562 [PubMed - in process]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου